首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study.
【24h】

Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study.

机译:是否有可能通过很少的实验数据对接新配体并为其评分?作为案例研究的雌激素受体的初步结果。

获取原文
获取原文并翻译 | 示例
           

摘要

Estrogens are steroid hormones playing critical roles in several physiological processes, which bind the estrogen receptors ERalpha and ERbeta. Aim of this work is to analyze, by different docking experiments, the behavior of a set of compounds, mimicking estrogens activity, in order to understand the relationship between ERalpha and such new ligands. Main goal is to verify, using a widely tested scoring software procedure applied on a set of 10 compounds, the possibility to produce new lead candidate molecules in lack of, or with few experimental data. Our preliminary results reveal the significance of HINT software as a scoring function in docking methodology and specifically, as a mean for assessing the consistency of docking solutions.
机译:雌激素是类固醇激素,在几种生理过程中起着关键作用,它们结合雌激素受体ERalpha和ERbeta。这项工作的目的是通过不同的对接实验来分析一组化合物的行为,模仿雌激素的活性,以了解ERalpha与此类新配体之间的关系。主要目标是,使用经过广泛测试的评分软件程序,对一组10种化合物进行验证,以验证缺乏或缺乏实验数据的情况下,产生新的潜在先导分子的可能性。我们的初步结果揭示了HINT软件在对接方法中作为评分功能的重要性,尤其是作为评估对接解决方案一致性的一种手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号